Literature DB >> 6807341

Purification of three iron-sulfur proteins from the iron-protein fragment of mitochondrial NADH-ubiquinone oxidoreductase.

C I Ragan, Y M Galante, Y Hatefi.   

Abstract

A fragment containing non-heme iron and acid-labile sulfide but little flavin can be solubilized from the mitochondrial NADH-ubiquinone oxidoreductase complex with chaotropic agents. This iron-protein fragment [Hatefi, Y., & Stempel, K. E. (1969) J. Biol. Chem. 244, 2350] has been resolved with detergents and ammonium sulfate fractionation into iron and acid-labile sulfide containing fractions, here called ISP-I and ISP-(II + III). ISP-I consists predominantly of a single polypeptide of molecular weight 75000. ISP-(II + III) consists predominantly of three polypeptides in equimolar concentrations with molecular weights of 49,000, 30000, and 13000. Treatment of the latter with sodium trichloroacetate followed by ammonium sulfate fraction results in separation of the 49000 molecular weight polypeptide from the two smaller subunits. Both of these subfractions (ISP-II and ISP-III, respectively) contain non-heme iron. The three iron-sulfur proteins have been characterized by their absorption spectra and iron and acid-labile sulfide contents. On the basis of the distribution of iron among the fractions obtained from chaotropic resolution of the NADH-ubiquinone oxidoreductase complex, a minimum of six or seven iron-sulfur centers are present in this enzyme.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6807341     DOI: 10.1021/bi00539a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  cDNA of the 24 kDa subunit of the bovine respiratory chain NADH dehydrogenase: high sequence conservation in mammals and tissue-specific and growth-dependent expression.

Authors:  A Chomyn; S S Lai
Journal:  Curr Genet       Date:  1989-08       Impact factor: 3.886

2.  The effect of rate limitation by cytochrome c on the redox state of the ubiquinone pool in reconstituted NADH: cytochrome c reductase.

Authors:  J S Reed; C I Ragan
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

Review 3.  Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases.

Authors:  J A Morgan-Hughes; A H Schapira; J M Cooper; J B Clark
Journal:  J Bioenerg Biomembr       Date:  1988-06       Impact factor: 2.945

4.  Mitochondrial myopathy with succinate dehydrogenase and aconitase deficiency. Abnormalities of several iron-sulfur proteins.

Authors:  R E Hall; K G Henriksson; S F Lewis; R G Haller; N G Kennaway
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

5.  Chemical cross-linking of mitochondrial NADH dehydrogenase from bovine heart.

Authors:  M W Cleeter; S H Banister; C I Ragan
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

6.  Deficiency of the iron-sulfur clusters of mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis.

Authors:  R W Moreadith; M L Batshaw; T Ohnishi; D Kerr; B Knox; D Jackson; R Hruban; J Olson; B Reynafarje; A L Lehninger
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

7.  The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

8.  Immunochemical probing of the structure and cofactor of NADH dehydrogenase from Paracoccus denitrificans.

Authors:  C L George; S J Ferguson
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

9.  Structural studies on mitochondrial NADH dehydrogenase using chemical cross-linking.

Authors:  S D Patel; C I Ragan
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

10.  Photoaffinity labelling of mitochondrial NADH dehydrogenase with arylazidoamorphigenin, an analogue of rotenone.

Authors:  F G Earley; C I Ragan
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.